Grifols Strengthens Presence In US Where It Now Generates Over 60% Of Sales

Spanish pharmaceutical and healthcare firm Grifols has obtained approval from the US Food and Drug Administration (FDA) to market the physiological saline solution which the company manufactures at its plant in Las Torres de Cotillas (Murcia). This is very positive for the group’s hospital division and, in particular, for its presence in the US.

Juncker investment plan in Spain

The Junker Plan: Much Ado About Nothing

There has been a lot of song and dance about extending the ‘Junker Plan’ to promote investments of up to 630 billion euros over the next six years. But the fact is that, up to now, projects worth 116 billion euros have been approved under the auspices of the Plan, according to the European Commission (EC)’s own estimates.

No Picture

Grifols sees net profit jump of 34.8%

BARCELONA | 16.8% of sales generated in Latin America, Asia-Pacific and R.O.W., the USA and Canada account for 60.0% of sales and Europe represents 21.8%. 8% of sales generated in Spain.